Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROGASS: Prucalopride on Gastroenteric Transit in Systemic Sclerosis
2012-005348-92Phase 4Active
- Sponsor
- Policlinico di Milano
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prucalopride in systemic sclerosis (SSc), constipation, gastroesophageal reflux disease (GERD), Gastrointestinal Dysmotility, sponsored by Policlinico di Milano. Started Jan 2013; status: active.
02
Drugs
prucalopride
03
Conditions
systemic sclerosis (SSc)constipationgastroesophageal reflux disease (GERD)Gastrointestinal Dysmotility
Beyond the preview
Go deeper on 2012-005348-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005348-92.